5YS2 image
Deposition Date 2017-11-12
Release Date 2017-12-27
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5YS2
Keywords:
Title:
Structure of the domain IV(D_IV) of Pseudorabies virus glycoprotein B( PRV gB)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.29
R-Value Work:
0.22
R-Value Observed:
0.23
Space Group:
P 2 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein B,Envelope glycoprotein B
Chain IDs:A, B, C, D, E, F
Chain Length:254
Number of Molecules:6
Biological Source:Suid alphaherpesvirus 1
Ligand Molecules
Primary Citation
Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design.
PLoS Pathog. 13 e1006777 e1006777 (2017)
PMID: 29261802 DOI: 10.1371/journal.ppat.1006777

Abstact

Pseudorabies virus (PRV) belongs to the Herpesviridae family, and is an important veterinary pathogen. Highly pathogenic PRV variants have caused severe epidemics in China since 2011, causing huge economic losses. To tackle the epidemics, we identified a panel of mouse monoclonal antibodies (mAbs) against PRV glycoprotein B (gB) that effectively block PRV infection. Among these 15 mAbs, fourteen of them block PRV entry in a complement-dependent manner. The remaining one, 1H1 mAb, however can directly neutralize the virus independent of complement and displays broad-spectrum neutralizing activities. We further determined the crystal structure of PRV gB and mapped the epitopes of these antibodies on the structure. Interestingly, all the complement-dependent neutralizing antibodies bind gB at the crown region (domain IV). In contrast, the epitope of 1H1 mAb is located at the bottom of domain I, which includes the fusion loops, indicating 1H1 mAb might neutralize the virus by interfering with the membrane fusion process. Our studies demonstrate that gB contains multiple B-cell epitopes in its crown and base regions and that antibodies targeting different epitopes block virus infection through different mechanisms. These findings would provide important clues for antiviral drug design and vaccine development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures